Shares of Health Care sector company Hologic moved -0.0% today, and are now trading at a price of $65.5. The Large-Cap stock's daily volume was 47,157 compared to its average volume of 1,862,239. The S&P 500 index returned a -1.0% performance.
Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company is based in Marlborough and has 7,063 full time employees. Its market capitalization is $14,568,640,512.
14 analysts are following Hologic and have set target prices ranging from $65.0 to $80.0 per share. On average, they have given the company a rating of buy. At today's prices, HOLX is trading -10.36% away from its average analyst target price of $73.07 per share.
Over the last year, HOLX shares have gone down by -19.8%, which represents a difference of -34.2% when compared to the S&P 500. The stock's 52 week high is $84.39 per share and its 52 week low is $51.9. With average free cash flows of $1.31 Billion that have been growing at an average rate of 11.8% over the last 5 years, Hologic declining stock performance may not be reflective of the quality of its underlying business.
| Date Reported | Cash Flow from Operations ($ k) | Capital expenditures ($ k) | Free Cash Flow ($ k) | YoY Growth (%) |
|---|---|---|---|---|
| 2024 | 1,285,200 | 72,400 | 1,212,800 | 19.5 |
| 2023 | 1,051,200 | 36,300 | 1,014,900 | -50.62 |
| 2022 | 2,125,700 | 70,600 | 2,055,100 | -7.1 |
| 2021 | 2,330,400 | 118,300 | 2,212,100 | 177.1 |
| 2020 | 896,600 | 98,300 | 798,300 | 34.73 |
| 2019 | 649,500 | 57,000 | 592,500 |
